Point72 Europe »

Apellis Pharmaceuticals shares owned by Point72 Europe

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Point72 Europe

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.1M 193k 31.91

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
UBS Group
State Street Corporation
EcoR1 Capital
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management
Deutsche Bank Aktiengesellschaft

View all funds holding Apellis Pharmaceuticals